Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
12/2008
12/04/2008US20080299674 Novel Isonitrile Compound, Its Method Of Manufacture, A Marine Fouling Organism Larva Fluorescent, And A Method Of Detecting This Marine Fouling Organism Larva Using Said Marker
12/04/2008CA2687764A1 Ion channel modulators and methods of use
12/03/2008EP1997495A1 2-phenoxy- and 2-phenylsulfanyl-benzenesulfonamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/03/2008EP1996544A1 A method of preparation of (r)-(-)-5(2-aminopropyl)-2-methoxybenzenesulfonamide
12/03/2008CN101314581A N-sulfuryl ketimine compounds and preparation method thereof
12/03/2008CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same
12/03/2008CN100439329C 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
12/02/2008US7459585 Benzene derivatives and pharmaceutical use thereof
12/02/2008US7459580 Process for trans-4-amino-1-cyclohexanecarboxilic acid derivatives
12/02/2008US7459472 Aryl and heteroaryl compounds, compositions, and methods of use
12/02/2008CA2377668C Novel naphthylsulfonic acids and related compounds as glucose uptake agonists
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
11/2008
11/27/2008WO2008024303A3 Compounds for treating proliferative disorders
11/27/2008US20080293775 Substituted Diphenylethers, -Amines, -Sulfides and -Methanes for the Treatment of Respiratory Disease
11/27/2008US20080293751 Tetralin and indane derivatives and uses thereof
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/26/2008CN100436425C Fused imidazolium derivatives
11/20/2008WO2008139987A1 G-protein-conjugated receptor agonist
11/20/2008WO2008139152A1 N-oxide-containing pharmaceutical compounds
11/20/2008US20080287477 Novel Compounds as Modulators of Ppar
11/19/2008CN101309900A Substituted cycloalkene derivative
11/19/2008CN101309899A Fluorinated gemini surfactants
11/18/2008US7453010 trans-N-{5-[((2S)-3-{[4-(1,1'-Biphenyl-4-yl)cyclohexyl]amino}-2-hydroxypropyl)oxy]-2-hydroxyphenyl}methanesulfonamide; beta 3 receptor agonists; antiinflammtory agent; irritable bowel syndrome; obesity, diabeties, glaucoma, dysmenorrheal, depression, urinary incontinence, lipolysis or cicatrizing
11/18/2008US7452874 Thrombopoietin mimetics
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008113760A3 Arylsulphonyglycine derivatives as suppressors of the interaction of glycogen phosphorylase a with the gl subunit of glycogen-associated protein phosphatase 1 (ppl) for the treatment of metabolic disorders, particulary diabetes
11/13/2008US20080281095 Asparatyl protease inhibitor
11/12/2008EP1989174A1 Substituted cyclohexylmethyl derivatives
11/12/2008EP1893597B1 Ampa receptor potentiators
11/12/2008EP1624868B1 "(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)- propyl]phenyl derivatives as beta2 agonists
11/12/2008CN100432049C Cycloalkene derivatives, process for producing the same and use
11/06/2008WO2008132154A1 Methods for the preparation of n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives
11/06/2008WO2008113756A8 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
11/06/2008WO2008110698A3 Method for preparing fluorinated sulphanylamides and sulphinamidines and uses thereof
11/06/2008WO2008017925A3 Pharmacodynamic hybrids endowed of hypoglycemic and no-donor activities obtained combining hydroxylated derivatives of glibenclamide and nitrooxy-substituted carboxylic acids
11/06/2008US20080275216 Fluorous Capping Reagents and Methods for Peptide Purification
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275100 For inducing general anesthesia, sedation, and/or hypnotic or sleep effects in patient
11/06/2008DE102007020493A1 Substituierte Amid-Derivate Substituted amide derivatives
11/06/2008DE102007020492A1 Substituierte Sulfonamid-Derivate Substituted sulfonamide derivatives
11/06/2008CA2685503A1 Substituted amide derivatives
11/06/2008CA2682616A1 Methods for the preparation of n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives
11/05/2008EP1608374B1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008EP1053227B1 Ppar-gamma modulators
11/05/2008CN101300271A Collagen receptor I-domain binding modulators
11/05/2008CN100430377C N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/04/2008US7446222 2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-carboxylic acid; neuropathic pain; chronic articular pain (e.g. rheumatoid arthritis, osteoarthritis, rheumatoid spondylitis, gouty arthritis and juvenile arthritis) including the property of disease modification and joint structure preservation
11/04/2008CA2301943C Antimicrobial compounds
11/04/2008CA2256328C Novel n-acylsulphonamides, novel mixtures of herbicides and antidotes and their use
10/2008
10/30/2008WO2008131219A1 Substituted anthranilic acids
10/30/2008WO2008131047A2 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
10/30/2008WO2008130332A1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
10/30/2008WO2008129288A2 Disulfonamides useful in the treatment of inflammation
10/30/2008WO2008129276A1 Disulfonamides useful in the treatment of inflammation
10/30/2008WO2008088727A3 Endothelin receptor antagonists
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
10/30/2008CA2684591A1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
10/29/2008EP1984347A1 Selective n-sulfonylation of 2-amino trifluoroalkyl substituted alcohols
10/29/2008EP1984330A1 Chemical compounds
10/29/2008EP1216228B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
10/29/2008CN101296901A HIV-1 protease inhibitors, and methods of making and using them
10/29/2008CN101293900A Electrolytes for electrooptic devices comprising ionic liquids
10/29/2008CN101293860A Quaternary ammonium salt fluorine surfactant preparing method
10/29/2008CN100429200C Process for preparing acylsulfamoylbenzamides
10/28/2008USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent
10/28/2008US7442837 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442836 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442791 Aminoalkylamide substituted cyclohexyl derivatives
10/28/2008US7442719 Methods using phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442718 Inhibitors of aspartyl protease
10/28/2008US7442702 Prostaglandin agonists
10/28/2008CA2546602C Monoacyl-substituted guanidines
10/28/2008CA2230921C Process for the purification of diphenyl ether compounds
10/28/2008CA2229735C Process for nitrating diphenyl ether compounds
10/23/2008WO2008126731A1 Aryl derivatives
10/23/2008WO2008125296A1 Vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
10/23/2008WO2008040000A3 Soluble epoxide hydrolase inhibitors
10/23/2008US20080262089 Process for the Preparation of Tamsulosin
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261978 treating or preventing HIV infections, and in treating proliferative disorders such as inhibiting the metastasis of various cancers; 1-(4-((pyridin-2-ylmethylamino)methyl)benzyl)-3-phenylurea
10/23/2008US20080261966 Bis-aryl sulfonamides
10/23/2008US20080261956 Substituted Phenols as Active Agents Inhibiting Vegf Production
10/23/2008US20080261949 ethyl 4-[4-(2-hydroxy-3-(4-hydroxy-3-(methylsulphonylamino)phenoxy)propylamino)cyclohexyl]benzoic acid; beta-3 adrenergic receptor agonist; tocolytics; delaying preterm birth; antidiabetic; obesity; oxyalkylation of the phenyl(alkyl)cyclohexyl(alkyl)amine with a glycidyl ether
10/23/2008US20080261235 Novel Green and Orange Fluorescent Labels and Their Uses
10/22/2008EP1981873A1 Sulfonamide derivatives, preparation thereof and therapeutic use thereof
10/22/2008EP1981842A2 Sulfonamide derivatives, preparation and therapeutic application thereof
10/22/2008CN101291905A Phenyl-acetamide nnrt inhibitors
10/22/2008CN100427139C Water-soluble shps as novel alkylating agents
10/21/2008US7439394 Cyclohexyl-1,4-diamine compounds
10/21/2008US7439393 Phenethanolamine derivatives for treatment of respiratory diseases
10/21/2008US7439342 Thrombopoietin mimetics
10/21/2008US7439242 PPARγ modulators
10/16/2008WO2008124524A2 Aryl sulfonamide compounds as modulators of the cck2 receptor
10/16/2008WO2008123207A1 Ornithine derivative
10/16/2008WO2008122115A1 Inhibitors of histone deacetylase
10/16/2008US20080255240 Obesity; dietetics; hypotensive agents; antidiabetic agents; dyslipidemia; cardiovascular disorders; osteoarthritis; gall bladder disease; endometrosis; anticancer agents; vascular system disorders; apoptosis
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 177